Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Zhonghua Zhong Liu Za Zhi ; 39(5): 374-379, 2017 May 23.
Artículo en Zh | MEDLINE | ID: mdl-28535656

RESUMEN

Objective: In this study, we evaluated the effect of supraclavicular lymph node dissection in breast cancer patients who presented with ipsilateral supraclavicular lymph node metastasis (ISLM) without distant metastasis. Methods: A total of 90 patients with synchronous ISLM without distant metastasis between 2000 and 2009 were retrospectively analyzed. Patients were retrospectively divided into two groups, namely supraclavicular lymph node dissection group(34 patients) and non-dissection group(56 patients), according to whether they underwentsupraclavicular lymph node dissection or not.The Kaplan-Meier method was applied to analyze the locoregional relapse free survival (LRFS) and overall survival(OS). Results: Median follow-upwas 85 months(range, 6 to 11 months). Local recurrence in 32 cases, 47 cases of distant metastasis, of which 25 patients were accompanied by both locoregional relapse and distant metastasis. Of the 32 patients with locoregional relapse, 11 patients were in the lymph node dissection group and 21 patients in the control group. Of the 47 patients with distant metastases, 17 were treated with lymph node dissection, 30 in the control group. Thirty-two patients died in the whole group and 16 patients underwentlymph node dissection and 16 patients didn't. There was no significant difference between the rate of 5-year LRFS and 5-year OS (P=0.359, P=0.246). For patients of ER negative, the 5-year loco-regional relapse free survival rates were 63.7% and 43.3% in supraclavicular lymph node dissection group and control group, respectively. The 5-year overall survival rates were 52.1% and 52.3%, respectively, and there were no statistically significant differences (P=0.118, P=0.951). For patients of PR negative, the 5-yearloco-regional relapse free rates were 59.8% and 46.2%, respectively, and the 5-year overall survival rates were 50.6% and 43.2%, respectively, and there was no significant difference between the two groups (P=0.317, P=0.973). The 5-year recurrence-free survival rates of human epidermal growth factor receptor 2 (HER2)-positive patients were 61.2% and 48.0%(P=0.634), respectively, and the 5-year overall survival rates were 37.2% and 65.4%(P=0.032). Forty-seven patients suffered distant metastases and the 5-year metastases free survival rates were 37.3% and 38.5% in supraclavicular lymph node dissection group and control group, respectively. Conclusion: Supraclavicular lymph node dissection maybe an effective approach to improve the loco-regional control for the patients with ISLM, especially for ER negative and PR negative subtypes, but it might has adverseeffects for the patients with negative HER2 status.


Asunto(s)
Neoplasias de la Mama/cirugía , Escisión del Ganglio Linfático/métodos , Ganglios Linfáticos/patología , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/patología , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Estimación de Kaplan-Meier , Escisión del Ganglio Linfático/estadística & datos numéricos , Metástasis Linfática , Cuello , Recurrencia Local de Neoplasia , Receptor ErbB-2/metabolismo , Estudios Retrospectivos , Tasa de Supervivencia , Factores de Tiempo
2.
Inflamm Res ; 65(2): 103-14, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26566632

RESUMEN

OBJECTIVE AND DESIGN: Several works in the setting of early experimental diabetic nephropathy using anti-inflammatory drugs, such as the calcineurin inhibitor FK506, have shown prevention of the development or amelioration of renal injury including proteinuria. The exact mechanisms by which anti-inflammatory drugs lower the albuminuria have not been still clarified well. MATERIALS: The diabetic rats were induced by using streptozotocin. TREATMENT: The diabetic rats were subjected to oral FK506 treatment at a dose of 0.5 or 1.0 mg/kg daily for 4 weeks. METHODS: Renal histology for the ultrastructural evaluation was determined by electron microscope, followed by analyses of renal nephrin and podocin and detection of renal iNOS(+) macrophages and NF-κB-p-p65(+). RESULTS: Elevated 24-h urinary albumin excretion rate was markedly attenuated by FK506 treatment. In diabetic model rats, FK506 treatment at a dose of 0.5 or 1.0 mg/kg significantly increased the expression of nephrin and podocin when compared to control. As expected, rats in control diabetic group had an increase in GBM thickening and foot process effacement when compared to normal rats; increased GBM thickening and foot process effacement were ameliorated by FK506 treatment with 0.5 and 1.0 mg/kg. Histologically, there was marked accumulation of ED-1(+)cells (macrophages) in diabetic kidneys, and FK506 treatment failed to inhibit it. In contrast, FK506 treatment at 0.5 and 1.0 mg/kg doses significantly inhibited the elevated ED-1(+)/iNOS(+) cells in the kidneys of diabetic rats. ED-1(+)/NF-κB-p-p65(+) cells were significantly increased in positive diabetic kidneys compared to those of normal rats. FK506 treatment at 0.5 and 1.0 mg/kg significantly attenuated the elevated ED-1(+)/NF-κB-p-p65(+) cells in diabetic kidneys. Additionally, a positive correlation was observed between ED-1(+)/iNOS(+) cells and albuminuria (r = 0.87, p < 0.05). Likewise, ED-1(+)/iNOS(+) cells were correlated negatively with both nephrin and podocin protein (r = -0.70, p < 0.05; r = -0.68, p < 0.05, respectively). CONCLUSION: Our results show that FK506 not only upregulates expression of nephrin and podocin but also inhibits macrophage activation to protect against podocyte injury.


Asunto(s)
Albuminuria/metabolismo , Inhibidores de la Calcineurina/farmacología , Diabetes Mellitus Experimental/metabolismo , Péptidos y Proteínas de Señalización Intracelular/biosíntesis , Proteínas de la Membrana/biosíntesis , Tacrolimus/farmacología , Albuminuria/sangre , Albuminuria/tratamiento farmacológico , Albuminuria/patología , Animales , Glucemia/análisis , Inhibidores de la Calcineurina/uso terapéutico , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/patología , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Riñón/ultraestructura , Masculino , Microscopía Electrónica de Transmisión , Ratas , Tacrolimus/uso terapéutico
3.
Zhonghua Bing Li Xue Za Zhi ; 48(2): 154-155, 2019 Feb 08.
Artículo en Zh | MEDLINE | ID: mdl-30695873
4.
Eur Rev Med Pharmacol Sci ; 28(6): 2305-2316, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38567593

RESUMEN

OBJECTIVE: Residual kidney function (RKF) is an important prognostic indicator in peritoneal dialysis (PD) patients. So far, there are no prediction tools available for RKF, and the association between serum bicarbonate and RKF has received little attention in patients with PD. We aimed to develop a nomogram for the preservation of RKF based on the time-averaged serum bicarbonate (TA-Bic) levels. PATIENTS AND METHODS: A prediction model was established by conducting a retrospective cohort study of 151 PD patients who had been treated at the First Affiliated Hospital of Anhui Medical University. The nomogram was developed using a multivariate Cox regression model. The discrimination, calibration, and clinical utility of the model were evaluated by the C-index, receiver operating curve (ROC) curve, calibration curve, and decision curve analysis. RESULTS: In the elderly PD onset, higher baseline values of residual glomerular filtration rate, total Kt/V and higher TA-Bic levels were identified as protective predictors of RKF loss. The nomogram was conducted on the basis of the minimum value of the Akaike Information Criterion and Bayesian Information Criterion with a reasonable C-index of 0.766, showing great discrimination, proper calibration, and high potential for clinical practice. Through the total score of the nomogram, the patients were classified into the high-risk group and low-risk group, and a higher cumulative incidence of complete RRF loss was found in the high-risk group compared with the patients in the low-risk group. CONCLUSIONS: The novel predictive nomogram model can predict the probability of RKF preservation in long-term PD patients with high accuracy. Future studies are needed to externally validate the current nomogram before clinical application.


Asunto(s)
Bicarbonatos , Diálisis Peritoneal , Humanos , Anciano , Estudios Retrospectivos , Nomogramas , Teorema de Bayes , Factores de Riesgo , Riñón
6.
Zhonghua Yi Shi Za Zhi ; 53(6): 360-365, 2023 Nov 28.
Artículo en Zh | MEDLINE | ID: mdl-39069509

RESUMEN

Shang Han Lun Xuan Zhu(«¼,Annotation of Treatise on Febrile Diseases) is a representative work of Zang Yingzhan, a famous physician in Zhucheng of Shandong who was as famous as Huang Yuanyu during the Qianlong period of the Qing Dynasty.The book was not published, but has been preserved only in manuscripts, of which 5 copies are now preserved.By comparing the five manuscripts seen, it is found that the Zhuang Enze version is unique in the existing version of this book, exquisite and generous, beautifully copied, with important documentary value. Zhuang Enze adopts the theories of various schools, supplements prescriptions, analyze medical theory with his unique insights.The reason may be related to his family's practice of medicine for generations, its philosophy of loving reading, copying books, and collecting books, and also related to its protection of local and state documents and the dissemination of lost culture.


Asunto(s)
Fiebre , China , Fiebre/historia , Libros/historia , Medicina Tradicional China/historia , Humanos
7.
Eur Rev Med Pharmacol Sci ; 27(9): 3837-3845, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-37203808

RESUMEN

OBJECTIVE: This study aimed to explore the risk factors and etiological characteristics of urinary tract infection (UTI) in continuous ambulatory peritoneal dialysis (CAPD) patients. PATIENTS AND METHODS: A total of 90 CAPD patients with UTI comprised the infection group, while 32 CAPD patients without UTI constituted the control group. The risk factors and etiological characteristics of UTI were analyzed. RESULTS: Of the 90 bacterial strains isolated, 30 were Gram-positive (33.3%) and 60 were Gram-negative (66.7%). Urinary stones or urinary tract structural changes were more prevalent in the infection group (71.1%) than in the control group (46.9%) (χ² = 6.076, p = 0.018). The proportion of patients with residual diuresis less than 200 ml was higher in the infection group (50%) than in the control group (15.6%) (χ² = 11.533, p = 0.001). The distribution of primary disease differed between the two groups. Patients in the infection group had higher CAPD vintage, levels of triglycerides, fasting blood glucose, blood creatinine, blood phosphorus, and calcium-phosphorus product than those in the control group. Multivariate binary logistic regression analysis indicated that residual diuresis less than 200 ml (OR = 3.519, p = 0.039) and urinary stones or structural changes (OR = 4.727, p = 0.006) were independent risk factors for UTI. CONCLUSIONS: Urine cultures of CAPD patients with UTI contained a complex distribution of pathogenic bacteria. Urinary stones or structural changes and residual diuresis less than 200 ml were independent risk factors for UTI.


Asunto(s)
Diálisis Peritoneal Ambulatoria Continua , Cálculos Urinarios , Infecciones Urinarias , Humanos , Diálisis Peritoneal Ambulatoria Continua/efectos adversos , Infecciones Urinarias/epidemiología , Infecciones Urinarias/etiología , Factores de Riesgo , Fósforo
8.
Artículo en Zh | MEDLINE | ID: mdl-36878499

RESUMEN

Objective: To explore the reasonable time of prophylactic thyroidectomy for RET gene carriers in multiple endocrine neoplasia(MEN) 2A/2B families. Methods: From May 2015 to August 2021, RET gene carriers in MEN2A/MEN2B families were dynamically followed up at the Department of Thyroid Head and Neck Surgery, Beijing Tongren Hospital of Capital Medical University. The high-risk patients were encouraged to undergo prophylacitc total thyroidectomy according to the principle of "graded early warning system", namely the evaluation of gene detection, calcitonin value and ultrasound examination successively. Seven cases underwent the surgery, including 3 males and 4 females, aged from 7 to 29 years. According to the risk stratification listed in the guidelines of the American Thyroid Association in 2015, there were 2 cases of the highest risk, 2 cases of the high risk and 3 cases of the modest risk. Calcitonin index remained within the normal range in 3 cases and elevated in 4 cases before operation. All 7 patients underwent thyroidectomy with lymph node dissection of the level Ⅵ performed in 4 patients. Results: The time from suggestion to operation was 2 to 37 months, with an average of 15.1 months. The 6 patients were medullary thyroid carcinoma and 1 case with C-cell hyperplasia. The follow-up time was 2 to 82 months, with an average of 38.4 months. Postoperative serum calcitonin levels of all cases decreased to normal level, with biochemical cure. There was no sign of recurrence on ultrasound examination. All 7 patients had no serious complications, no obvious thyroid dysfunction. Their height, weight and other indicators of pediatric patients were similar to those of their peers, with normal growth and development. Conclusion: For healthy people with MEN2A/MEN2B family history, prophylactic thyroidectomy can be carried out selectively based on the comprehensive evaluation of "graded early warning system" with strict screening and close monitoring.


Asunto(s)
Neoplasia Endocrina Múltiple Tipo 2a , Neoplasia Endocrina Múltiple Tipo 2b , Femenino , Masculino , Humanos , Niño , Adolescente , Adulto Joven , Adulto , Neoplasia Endocrina Múltiple Tipo 2b/genética , Neoplasia Endocrina Múltiple Tipo 2b/cirugía , Tiroidectomía , Neoplasia Endocrina Múltiple Tipo 2a/genética , Neoplasia Endocrina Múltiple Tipo 2a/cirugía , Calcitonina , Mutación de Línea Germinal , Proteínas Proto-Oncogénicas c-ret/genética
10.
Eur Rev Med Pharmacol Sci ; 24(22): 11971-11976, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-33275274

RESUMEN

OBJECTIVE: This paper presents a newborn (G2P2, gestational age of 39+6 weeks, birth weight of 3,200 g, with normal fetal amniotic fluid) with suspected coronavirus disease 2019 (COVID-19) admitted to our hospital on February 10, 2020, at the birth age of 16 hours and 34 minutes. The Apgar scores at 1 and 5 min were 9 and 10 points, respectively. PATIENTS AND METHODS: The mother of the newborn was exposed to a patient with COVID-19 five days before delivery. The newborn had nausea and vomiting after birth, with feeding intolerance, and full enteral feeding was given on the 6th day after birth. The newborn was in good general condition during the period of hospitalization. RESULTS: The two 2019-nCoV nucleic acid tests of the newborn were negative on the 5th and 7th days after birth. On the 1st and 8th days after birth, typical pulmonary lesions were detected in the newborn by chest CT. Our study supports that chest imaging examination should be actively performed in the newborn even with a negative 2019-nCoV nucleic acid test in cases where a pregnant woman is exposed to a patient with COVID-19 or is confirmed with 2019-nCoV infection. CONCLUSIONS: For newborns with typical pulmonary lesions, strict quarantine measures are suggested if the possibility of COVID-19 cannot be excluded.


Asunto(s)
Prueba de Ácido Nucleico para COVID-19 , COVID-19/diagnóstico por imagen , Pulmón/diagnóstico por imagen , Exposición Materna , Náusea/fisiopatología , Complicaciones Infecciosas del Embarazo/diagnóstico , Tomografía Computarizada por Rayos X , Vómitos/fisiopatología , Ambroxol , Antibacterianos/uso terapéutico , Ácido Ascórbico/uso terapéutico , Lactancia Materna , Proteína C-Reactiva/metabolismo , COVID-19/metabolismo , COVID-19/fisiopatología , COVID-19/terapia , Expectorantes/uso terapéutico , Femenino , Humanos , Recién Nacido , Masculino , Nutrición Parenteral , Embarazo , Proteína Amiloide A Sérica/metabolismo , Vitaminas/uso terapéutico
11.
Oncogene ; 25(4): 588-98, 2006 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-16205646

RESUMEN

Cervical cancer is associated with human papilloma virus infection. However, this infection is insufficient to induce transformation and progression. Loss of heterozygosity analyses suggest the presence of a tumor suppressor gene (TSG) on chromosome 6p21.3-p25. Here we report the cloning NOL7, its mapping to chromosome band 6p23, and localization of the protein to the nucleolus. Fluorescence in situ hybridization analysis demonstrated an allelic loss of an NOL7 in cultured tumor cells and human tumor samples. Transfection of NOL7 into cervical carcinoma cells inhibited their growth in mouse xenografts, confirming its in vivo tumor suppressor activity. The induction of tumor dormancy correlated with an angiogenic switch caused by a decreased production of vascular endothelial growth factor and an increase in the production of the angiogenesis inhibitor thrombospondin-1. These data suggest that NOL7 may function as a TSG in part by modulating the expression of the angiogenic phenotype.


Asunto(s)
Nucléolo Celular/química , Genes Supresores de Tumor , Neovascularización Patológica/prevención & control , Neoplasias del Cuello Uterino/genética , Animales , Línea Celular Tumoral , Mapeo Cromosómico , Cromosomas Humanos Par 6 , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Ratones , Trombospondina 1/genética , Neoplasias del Cuello Uterino/irrigación sanguínea , Factor A de Crecimiento Endotelial Vascular/genética
12.
Artículo en Zh | MEDLINE | ID: mdl-28910901

RESUMEN

T cell immune checkpoint pathways contribute to tumor immune escape. Many studies have shown that immune checkpoint is demonstrably correlated with tumor grade or prognosis in several types of malignancies and immune checkpoint has become a new biological index for tumor detection and prognosis. Immune checkpoint inhibitors have shown promising tumor outcomes in clinical trials for some advanced solid tumors and it will become a new target for cancer immunotherapy. In this review we will explore the correlation between expressions of immune checkpoint-associated genes and proteins in immune microenviroment and prognosis of head and neck squamous cell carcinoma, and specifically will discuss how this pathway can be manipulated with immune therapeutic drugs.


Asunto(s)
Inmunoterapia , Carcinoma de Células Escamosas de Cabeza y Cuello/inmunología , Carcinoma de Células Escamosas de Cabeza y Cuello/terapia , Escape del Tumor/inmunología , Humanos , Pronóstico , Carcinoma de Células Escamosas de Cabeza y Cuello/genética , Linfocitos T/inmunología , Escape del Tumor/genética
13.
Oncogene ; 15(23): 2849-53, 1997 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-9419976

RESUMEN

Transient elevation of cytosolic Ca2+ induces the expression of a variety of genes involved in cell growth and transformation, including the early response gene c-fos. Previously, we reported that Bcl-2 inhibits the transient elevation of cytosolic Ca2+ induced by thapsigargin (TG), a selective inhibitor of the endoplasmic reticulum-associated Ca2+-ATPase. Therefore, to determine if the effect of Bcl-2 on cytosolic Ca2+ elevation modulates Ca2+ signaling, we investigated the induction of c-fos by TG in WEHI7.2 mouse lymphoma cells, control transfectants (WEHI7.2-neo), and transfectants that stably express a high level of Bcl-2 (W.Hb12 and W.Hb15). TG induced 20-fold elevation of c-fos mRNA in WEHI7.2 and WEHI7.2-neo cells, but c-fos mRNA induction by TG was only fivefold in W.Hb12 and W.Hb15 cells. In contrast, phorbol 12-myristate acetate induced marked c-fos mRNA elevation in both WEHI7.2 and W.Hb12 cells, indicating that the inhibitory effect of Bcl-2 is selective for induction of c-fos by Ca2+. To measure c-fos promoter activity, WEHI7.2 and W.Hb12 cells were transiently transfected with a c-fos promoter-luciferase reporter plasmid. TG induced c-fos promoter activity in WEHI7.2 cells, but not in W.Hb12 cells. In WEHI7.2 cells, the signal for c-fos induction by TG was cytosolic Ca2+ elevation, as the increase in both c-fos mRNA level and promoter activity were prevented by lowering extracellular Ca2+ concentration, a condition that inhibits cytosolic Ca2+ elevation by reducing the TG-mobilizable Ca2+ pool. In summary, the findings indicate that Bcl-2 regulates Ca2+ signaling.


Asunto(s)
Calcio/antagonistas & inhibidores , Calcio/fisiología , Regulación Neoplásica de la Expresión Génica , Genes fos , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Transducción de Señal/genética , Animales , Citosol/metabolismo , Citosol/fisiología , Espacio Extracelular/metabolismo , Espacio Extracelular/fisiología , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Genes fos/efectos de los fármacos , Linfoma , Ratones , Ratones Endogámicos BALB C , Regiones Promotoras Genéticas/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Acetato de Tetradecanoilforbol/farmacología , Tapsigargina/farmacología , Transfección , Células Tumorales Cultivadas
14.
Oncogene ; 15(10): 1207-12, 1997 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-9294614

RESUMEN

Programmed cell death, or apoptosis, is inhibited by the antiapoptotic oncogene, Bcl-2, and is mediated by a cascade of aspartate-specific cysteine proteases, or caspases, related to interleukin 1-beta converting enzyme. Depending on cell type, apoptosis can be induced by treatment with thapsigargin (TG); a selective inhibitor of the endoplasmic reticulum-associated calcium-ATPase. The role of caspases in mediating TG-induced apoptosis was investigated in the Bcl-2-negative human breast cancer cell line, MDA-MB-468. Apoptosis developed in MDA-MB-468 cells over a period of 24-72 h following treatment with 100 nM TG, and was prevented by Bcl-2 overexpression. TG-induced apoptosis was associated with activation of caspase-3 and was inhibited by stable expression of the baculovirus p35 protein, an inhibitor of caspase activity. Also, TG-induced apoptosis was inhibited by treating cells with Z-VAD-fmk, a cell-permeable fluoromethylketone inhibitor of caspases. These findings indicate that TG-induced apoptosis of MDA-MB-468 breast cancer cells is subject to inhibition by Bcl-2 and is mediated by caspase activity. This model system should be useful for further investigation directed toward understanding the role of calcium in signaling apoptosis, and its relationship to Bcl-2 and the caspase proteolytic cascade.


Asunto(s)
Clorometilcetonas de Aminoácidos/farmacología , Apoptosis/efectos de los fármacos , Neoplasias de la Mama/patología , Caspasas , Cisteína Endopeptidasas/fisiología , Inhibidores de Cisteína Proteinasa/farmacología , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Tapsigargina/farmacología , Proteínas Virales/farmacología , Caspasa 3 , Cisteína Endopeptidasas/metabolismo , Activación Enzimática , Humanos , Proteínas Inhibidoras de la Apoptosis , Transducción de Señal , Células Tumorales Cultivadas
15.
Chemosphere ; 61(2): 158-67, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16168739

RESUMEN

In recent years, several plant species have been used as bioindicators, and several tests have been developed to evaluate the toxicity of environmental contaminants on vegetal organisms. In this study, barley (Hordeum vulgare L) seedling was used as bioindicator of cadmium (Cd) pollution in the range of 30-120 mgl(-1). Inhibition of root growth and reduction of total soluble protein content in root tips of barley seedlings were observed with the increase of Cd concentrations. The changes occurring in random amplified polymorphic DNA (RAPD) profiles of root tips following Cd treatment included variation in band intensity, loss of normal bands and appearance of new bands compared with the normal seedlings. Additionally, we found that the effect of changes was dose-dependent. These results indicated that genomic template stability (a qualitative measure reflecting changes in RAPD profiles) was significantly affected at the above Cd concentration. Thus, DNA polymorphisms detected by RAPD analysis could be used as an investigation tool for environmental toxicology and as a useful biomarker assay for the detection of genotoxic effects of Cd pollution on plants.


Asunto(s)
Cadmio/toxicidad , Daño del ADN , Hordeum/genética , Contaminantes del Suelo/toxicidad , Biomarcadores , Raíces de Plantas/crecimiento & desarrollo , Polimorfismo Genético , Técnica del ADN Polimorfo Amplificado Aleatorio , Plantones
16.
Zhongguo Zhong Yao Za Zhi ; 19(5): 286-7, 320, 1994 May.
Artículo en Zh | MEDLINE | ID: mdl-7945869

RESUMEN

The HPLC analysis has been carried out by using the ultrasphere-ODS column and methanol-water as mobile phase. The lowest limit of determination is 0.4 microgram. The relative standard deviation of different sample concentrations is 2.41%.


Asunto(s)
Ácido Oleanólico/análisis , Cromatografía Líquida de Alta Presión , Comprimidos/química
20.
Inflamm Res ; 55(5): 192-9, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16830106

RESUMEN

OBJECTIVE AND DESIGN: Previously it was shown that blocking of the renin-angiotensin system (RAS) by angiotensin converting enzyme (ACE) inhibitors, or suppression of inflammatory responses by immunosuppressive drugs such as mycophenolate mofetil (MMF) could attenuate renal injury in diabetic rats. Whether RAS blockade combined with an immunosuppressive drug provides superior renoprotection against diabetic nephropathy has not been clearly delineated. MATERIALS: Diabetes was induced by injection of streptozotocin after uninephrectomy. TREATMENT: Rats were randomly separated into five groups: control, diabetes, diabetes treated with enalapril (an ACE inhibitor, 10 mg/kg/d by gastric gavage), diabetes treated with MMF (10 mg/kg/d by gastric gavage), or diabetes treated with a combination of both agents and were followed for 8 weeks. METHODS: 24 h urinary albumin excretion rate (AER) was determined, renal injury was evaluated, immunohistochemistry for ED-1 macrophage marker, intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) were performed, and expression of transforming growth factor (TGF)-beta1 protein was determined by Western blotting analysis. RESULTS: Diabetes was associated with a considerable increase in AER. Both enalapril and MMF retarded the increase in albuminuria, which was nearly completely abrogated by combination therapy. Increased glomerular volume and tubulointerstitial injury index in diabetic rats was attenuated by treatment with either enalapril or MMF and further reduced by the combination of the two. Elevated malondialdehyde levels in renal tissue were reduced by enalapril or MMF and, more effectively, by combined enalapril with MMF. Renal overexpression of ICAM-1 was not retarded by enalapril and attenuated by MMF or combined enalapril with MMF. Combination therapy was associated with a superior suppression of diabetes-induced macrophage recruitment and overexpression of MCP-1 and TGFbeta1 compared to either monotherapy in renal tissue. CONCLUSION: The combination of enalapril and MMF confers superiority over monotherapy in renoprotection, a mechanism which may be at least partly correlated with synergistic suppression of increased macrophage recruitment and overexpression of MCP-1 and TGF-beta1 in renal tissue in diabetic rats.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Diabetes Mellitus Experimental/tratamiento farmacológico , Enalapril/farmacología , Inmunosupresores/farmacología , Ácido Micofenólico/análogos & derivados , Albuminuria/tratamiento farmacológico , Animales , Quimiocina CCL2/metabolismo , Diabetes Mellitus Experimental/inmunología , Diabetes Mellitus Experimental/metabolismo , Quimioterapia Combinada , Molécula 1 de Adhesión Intercelular/metabolismo , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Masculino , Malondialdehído/metabolismo , Ácido Micofenólico/farmacología , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Factor de Crecimiento Transformador beta/metabolismo , Factor de Crecimiento Transformador beta1
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda